Large mergers and acquisitions in the Indian pharmaceutical market are unlikely soon due to various uncertainties, says GV ...

Most organizations can afford a 10% efficiency cut, providing immediate financial relief, but how these cuts are done often ...

In addition to a continued focus on growing drug pipelines, and the increasing use of artificial intelligence (AI) and data ...

With proper data governance, the pharma industry can improve patient-centricity in trials and bring lifesaving therapies to ...

Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...

In November 2024, Zealand Pharma presented detailed results from the Phase 1b 16-week multiple ascending dose (MAD) trial at ...

At this point in time, countries are trying to be self-sufficient in pharma and companies and countries are trying to be balanced from a tariff perspective. “So, technology-transfer functions ...

Mallinckrodt and Endo are merging in a cash and stock deal worth some $6.7 billion, the companies said Thursday. Under the ...

Indian pharma companies are expanding in the US through acquisitions to navigate regulations, diversify portfolios, and ...

Robert F. Kennedy Jr.’s health policies are stirring debate—here’s what they mean for you and the future of healthcare.